Evidence map›Paper›PMID 32623745›Full record

ArticleJournal of cutaneous pathology2021

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta-catenin) mutation.

Jenny Giang, Asok Biswas, Antien L Mooyaart, Floris H Groenendijk, Petra Dikrama, Jeffrey Damman

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of cutaneous pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jenny GiangDepartment of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-4982-963X
Asok BiswasDepartment of Pathology, Western General Hospital, University of Edinburgh, Edinburgh, UK.
Antien L MooyaartDepartment of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Floris H GroenendijkDepartment of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Petra DikramaDepartment of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jeffrey DammanDepartment of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLWestern General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of trichoblastic carcinosarcoma with panfollicular differentiation. An 80-year-old man presented with a lesion on the left ear, which had been present for several months. Histopathology revealed a well-demarcated neoplasm in the dermis composed of intimately intermingled malignant epithelial and mesenchymal cells. The epithelial component showed multilineage follicular differentiation toward all of the elements of a normal hair follicle. Molecular analysis revealed identical molecular aberrations in both epithelial and mesenchymal components including CTNNB1 and SUFU mutations. To the best of our knowledge, this is the first report of panfollicular carcinosarcoma and of the presence of a CTNNB1 mutation in trichoblastic carcinosarcoma.

Indexed as

beta CateninCarcinosarcomaMutationNeoplasm ProteinsSkin NeoplasmsAged, 80 and overHumansMaleRepressor Proteinsbeta CateninCTNNB1 protein, humanNeoplasm ProteinsRepressor ProteinsSUFU protein, human

Identifiers

PMID32623745
PMCPMC7891381
OpenAlexW3039816040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.